Compound information
- Natural Products
- ZC272898
- Molecular Formula
- C11H13N3O4
- Molecular Weight
- 251.090605896 g/mol
- Structure
-
- IUPAC Name
- N-(4-nitrophenyl)morpholine-4-carboxamide
- InChI
- InChI=1S/C11H13N3O4/c15-11(13-5-7-18-8-6-13)12-9-1-3-10(4-2-9)14(16)17/h1-4H,5-8H2,(H,12,15)
- InChI Key
- NBIPSUSFQGFVLH-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCOCC1
- Source
- ZINC000004156173
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 84.71 Å2 | LogP | 1.332 |
LogS | -2.538 | LogD | 1.662 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.027 | Pgp substrate | 0.063 |
HIA | 0.969 | F20 % | 0.98 |
F30 % | 0.323 | Caco-2 | -4.703 |
MDCK | -5.185 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.644 | PPB | 72.092 |
VD | 0.851 | Fu | 0.472 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.122 | CYP1A2 substrate | 0.696 |
CYP2A6 substrate | 0.784 | CYP2B6 substrate | 0.627 |
CYP2C19 inhibitor | 0.114 | CYP2C19 substrate | 0.866 |
CYP2C8 substrate | 0.737 | CYP2C9 inhibitor | 0.051 |
CYP2C9 substrate | 0.086 | CYP2D6 inhibitor | 0.051 |
CYP2D6 substrate | 0.854 | CYP2E1 substrate | 0.883 |
CYP3A4 inhibitor | 0.014 | CYP3A4 substrate | 0.946 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.227 | CL | 6.249 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.059 | Hepatotoxicity | 0.87 |
Mutagenicity | 0.815 | Rat Oral Acute Toxicity | 0.311 |
FDAMDD | 0.159 | Skin Sensitization | 0.999 |
Carcinogenicity | 0.959 | Eye Corrosion | 0.013 |
Eye Irritation | 0.599 | Respiratory Toxicity | 0.181 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.34 | IGC50 | 2.558 |
LC50FM | 2.571 | LC50DM | 1.189 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.231 | NR-AR-LBD | 0.28 |
NR-AhR | 0.885 | NR-Aromatase | 0.047 |
NR-ER | 0.551 | NR-ER-LBD | 0.419 |
NR-PPAR-gamma | 0.217 | SR-ARE | 0.827 |
SR-ATAD5 | 0.58 | SR-HSE | 0.124 |
SR-MMP | 0.293 | SR-p53 | 0.582 |
Similar covalent drugs
No similar covalent drugs found for this compound.